A spoonful of technology helps the medicine go down

Professor Yahya Choonara designs new and innovative ways of delivering drugs into the human body with the intention of reducing side effects, enhancing drug bioavailability and improving patient compliance. He is an asso­ciate professor of pharma­ceutics in the department of pharmacy­ and pharmacology at the University of the Witwatersrand (Wits) and the research manager of the Wits advanced drug-delivery platform. He has published over 60 research papers and presented over 150 conference papers, although he is only 31 years old.

His research focuses on the develop­ment of rate-modulated biode­gradable polymeric devices for prolonged drug delivery. "'Polymers' describe material that controls the release of the drug," says Choonara.

His work in intraocular im­plan­table drug-delivery devices to treat posterior segment eye diseases is of particular interest. An example of this type of eye disease is cytomegalo­virus retinitis, an ­infection in HIV/Aids patients that often leads to blindness. Current successful treatments can be very expensive and, if embedded in the eye, need to be removed later.

Choonara's design is a patent-pending biodegradable doughnut-shaped mini-tablet (DSMT) device that can provide constant drug release for six months to a year. Insertion involves initial eye surgery. The technology is simple to manufacture­ and a cost-effective treatment for these eye diseases.

"The DSMT device can be used for many diseases that require chronic suppressive maintenance therapy," says Choonara.

Drug­delivery technology
It can be placed anywhere in the body and doesn't need to be removed owing to its biodegradable properties. Examples of applications include the alle­viation of chronic inflammation and as an intrauterine device.

Choonara is also co-inventor of over 30 filed patents in drug­delivery technology. Wafer formulations, for example, are taken by mouth and dissolve in seconds. This is particularly useful for paediatric use but there are numerous other applications.

As part of his unique research approach, Choonara developed new ways of using existing software in the development of drug-delivery technology that allows formulation scientists to reduce experimentation time in the lab and on animals, and reduces cost.

While doing his undergraduate degree in pharmacy, Choonara was drawn to pharmaceutics and ways to design effective new formu­lations.

"Because many new drugs aren't stable, it was clear that there was a need for improved delivery systems to formulate drugs into effective products. Designing new drug molecules is very expensive and these need to be delivered effectively into the body," he says.

In South Africa the Wits drug-delivery platform is the only ­platform in its domain. It is directed by Professor Viness Pillay, who is a National Research Foundation/department of science and technology research chair, professor of ­pharmaceutics and head of pharmaceutics and pharmaceutical research at Wits. "I would like to acknowledge my mentor, Professor Pillay, who has been instrumental in allowing me to follow this vibrant path of research," says Choonara.

Choonara has his eye on a number of exciting research areas. "An example is using electronics and stimulatory response mechanisms in drug delivery," he says. "In future we may see drug-delivery systems in the body controlled by an external interface such as an iPad or cellphone."


Workers fight job-creation ‘mess’

Former Ekurhuleni workers argued in court that a programme promising to equip them with skills simply acted as a labour broker for the municipality

Court dissolves local municipality

Landmark judgment paves the way for South Africans to use legal system to hold councils responsible

Mabuza’s ‘distant relative’ scored big

Eskom’s woes are often because of boiler problems at its power plants. R50-billion has been set aside to fix them, but some of the contracts are going to questionable entities

ANC faction gunning for Gordhan

The ambush will take place at an NEC meeting about Eskom. But the real target is Cyril Ramaphosa

Press Releases

New-style star accretion bursts dazzle astronomers

Associate Professor James O Chibueze and Dr SP van den Heever are part of an international team of astronomers studying the G358-MM1 high-mass protostar.

2020 risk outlook: Use GRC to build resilience

GRC activities can be used profitably to develop an integrated risk picture and response, says ContinuitySA.

MTN voted best mobile network

An independent report found MTN to be the best mobile network in SA in the fourth quarter of 2019.

Is your tertiary institution is accredited?

Rosebank College is an educational brand of The Independent Institute of Education, which is registered with the Department of Higher Education and Training.

Is your tertiary institution accredited?

Rosebank College is an educational brand of The Independent Institute of Education, which is registered with the Department of Higher Education and Training.

VUT chancellor, Dr Xolani Mkhwanazi, dies

The university conferred the degree of Doctor of Science Honoris Causa on Dr Xolani Mkhwanazi for his outstanding leadership contributions to maths and science education development.

Innovate4AMR now in second year

SA's Team pill-Alert aims to tackle antimicrobial resistance by implementing their strategic intervention that ensures patients comply with treatment.

Medical students present solution in Geneva

Kapil Narain and Mohamed Hoosen Suleman were selected to present their strategic intervention to tackle antimicrobial resistance to an international panel of experts.